GLP-1 medication use has exploded in recent years
July 2, 2025: People Who Lost Their Vision After Taking Wegovy May Have New Legal Options In late June, 21 people who experienced vision loss after taking Wegovy or Ozempic requested to combine their lawsuits in New Jerseys state court system
Clinical evidence comes in tiers: mechanistic studies (does the molecule do what it should at the cellular level?), animal studies (does it produce the expected effect in a living organism?), and human trials (does it actually work on the people who will use it?)
GLP-1 medications have a lower eligibility threshold, meaning more women qualify sooner
Frontiers in Pharmacology, 12, 627533
Last Friday I had the chance to lead a workshop on this topic at the New York Society of Addiction Medicine NYSAM conference with two outstanding Icahn School of Medicine at Mount Sinai psychiatrists, Brendan Ross and @James Young